Loading
NYSEHealthcareMedical - Distribution
Latest quote
$0.4432
−$0.0297 · -6.28%
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Previous close
$0.4432
−$0.0297 · -6.28%
Pre-market
$0.459
+$0.0158 · +3.56%
Oct 9, 4:00 AM ET
Regular session · ET · Market data may be delayed.
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Day range
Current $0.4432
52-week range
Current $0.4432
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
82
Deep Value
Sentiment
59
Mixed
Risk
74
High Risk
Momentum
48
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Day range
Current $0.4432
52-week range
Current $0.4432
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76B USD | 10.7B USD | 10.33B USD | 9.96B USD | 9.79B USD |
| Cost of goods sold | 1.47B USD | 8.48B USD | 8.21B USD | 8.13B USD | 8.27B USD |
| Gross profit | 1.29B USD | 2.22B USD | 2.13B USD | 1.83B USD | 1.51B USD |
| Research and development | — | — | — | — | 12.1M USD |
| Selling, general, and administrative | 1.07B USD | 1.91B USD | 1.81B USD | 1.55B USD | 1.08B USD |
| Operating expenses | 1.07B USD | 2.43B USD | 2.02B USD | 1.68B USD | 1.14B USD |
| Interest expense | 107.18M USD | 143.8M USD | 157.92M USD | 128.89M USD | 48.09M USD |
| Depreciation and amortization | 214.52M USD | 264.78M USD | 287.38M USD | 228.67M USD | 90.62M USD |
| Operating income | 221.74M USD | −207.77M USD | 104.51M USD | 142.91M USD | 368.47M USD |
| Net income | −1.1B USD | −362.69M USD | −41.3M USD | 22.39M USD | 221.59M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$1.50
238.45% upsideCash distributions grouped by calendar year; partial years are marked.
$0.009
2021 complete year-99.1% since 2017
$1.03
2,017
$0.855
2,018
$0.01
2,019
$0.0095
2,020
$0.009
2,021
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Dec 14, 2021 | $0.002Quarterly | Dec 15, 2021 | Dec 31, 2021 |
Dividend | Sep 14, 2021 | $0.002Quarterly | Sep 15, 2021 | Sep 30, 2021 |
Dividend | Jun 14, 2021 | $0.0025Quarterly | Jun 15, 2021 | Jun 30, 2021 |
Dividend | Mar 12, 2021 | $0.0025Quarterly | Mar 15, 2021 | Mar 31, 2021 |
Dividend | Dec 14, 2020 | $0.0025Quarterly | Dec 15, 2020 | Dec 31, 2020 |
Dividend | Sep 14, 2020 | $0.002Quarterly | Sep 15, 2020 | Sep 30, 2020 |
Ex-dividend Dec 14, 2021
$0.002
Quarterly
Record Dec 15, 2021 · Payment Dec 31, 2021
Ex-dividend Sep 14, 2021
$0.002
Quarterly
Record Sep 15, 2021 · Payment Sep 30, 2021
Ex-dividend Jun 14, 2021
$0.0025
Quarterly
Record Jun 15, 2021 · Payment Jun 30, 2021
Ex-dividend Mar 12, 2021
$0.0025
Quarterly
Record Mar 15, 2021 · Payment Mar 31, 2021
Ex-dividend Dec 14, 2020
$0.0025
Quarterly
Record Dec 15, 2020 · Payment Dec 31, 2020
Ex-dividend Sep 14, 2020
$0.002
Quarterly
Record Sep 15, 2020 · Payment Sep 30, 2020
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI2.65M0.00%2.3T USD0.03%$379.56-0.39%
Vanguard U.S. Value Factor ETFVFVA1.46M0.17%957.4M USD0.13%$154.34+1.38%
Vanguard Extended Market ETFVXF1.01M0.00%95.4B USD0.05%$233.13-0.15%
iShares Russell 2000 ETFIWM953.06K0.00%77.7B USD0.19%$277.57-0.05%
Schwab Fundamental U.S. Small Company Index ETFFNDA597.26K0.01%8.72B USD0.25%$35.56+0.45%
Vanguard Russell 2000 ETFVTWO499.8K0.00%18B USD0.06%$112.1-0.10%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV250.27K0.00%26.69B USD0.33%$38.10+0.82%
Dimensional - US Targeted Value ETFDFAT245.87K0.00%30B USD0.33%$67.56+0.72%Vanguard Morningstar Total Stock Market ETFVTIVanguard U.S. Value Factor ETFVFVAVanguard Extended Market ETFVXFiShares Russell 2000 ETFIWMSchwab Fundamental U.S. Small Company Index ETFFNDAVanguard Russell 2000 ETFVTWOU.S. Small Cap Value Portfolio ETF Class SharesDFSVDimensional - US Targeted Value ETFDFATAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
